Population Pharmacokinetics of Dapsone in HIV-Infected Children

被引：0
|
作者：
Mark Mirochnick
Ellen Cooper
Jing Xu
Jane Lindsey
Edmund Capparelli
Ken McIntosh
James McNamara
Lynne M Mofenson
David Jacobus
机构：
[1] Pediatrics,
[2] Boston University School of Medicine,undefined
[3] Harvard School of Public Health,undefined
[4] Pediatrics,undefined
[5] University of California at San Diego,undefined
[6] Pediatrics,undefined
[7] Harvard University School of Medicine,undefined
[8] NIAID,undefined
[9] NICHD,undefined
[10] Jacobus Pharmaceutical Co,undefined
来源：
Pediatric Research | 1999年 / 45卷 / 7期
关键词：
D O I：
10.1203/00006450-199904020-00999
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：168 / 168
相关论文
共 50 条
  • [21] HIV-INFECTED CHILDREN
    不详
    LANCET, 1992, 339 (8807): : 1474 - 1475
  • [22] Population pharmacokinetics of delavirdine and N-delavirdine in HIV-infected individuals
    Smith, PF
    DiCenzo, R
    Forrest, A
    Shelton, M
    Friedland, G
    Para, M
    Pollard, R
    Fischl, M
    DiFrancesco, R
    Morse, GD
    CLINICAL PHARMACOKINETICS, 2005, 44 (01) : 99 - 109
  • [23] Population pharmacokinetics of dolutegravir in HIV-infected treatment-naive patients
    Zhang, Jianping
    Hayes, Siobhan
    Sadler, Brian M.
    Minto, Ilisse
    Brandt, Julie
    Piscitelli, Steve
    Min, Sherene
    Song, Ivy H.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 80 (03) : 502 - 514
  • [24] Population Pharmacokinetics of Delavirdine and N-Delavirdine in HIV-Infected Individuals
    Patrick F. Smith
    Robert DiCenzo
    Alan Forrest
    Mark Shelton
    Gerald Friedland
    Michael Para
    Richard Pollard
    Margaret Fischi
    Robin DiFrancesco
    Gene D. Morse
    Clinical Pharmacokinetics, 2005, 44 : 99 - 109
  • [25] Population pharmacokinetics of lopinavir and ritonavir in combination with rifampicin-based antitubercular treatment in HIV-infected children
    Zhang, Chao
    McIlleron, Helen
    Ren, Yuan
    van der Walt, Jan-Stefan
    Karlsson, Mats O.
    Simonsson, Ulrika S. H.
    Denti, Paolo
    ANTIVIRAL THERAPY, 2012, 17 (01) : 25 - 33
  • [26] Pharmacokinetics of antiretrovirals administered to HIV-infected children via gastrostomy tube
    King, JR
    Yogev, R
    Aldrovandi, G
    Chadwick, E
    Acosta, EP
    HIV CLINICAL TRIALS, 2004, 5 (05): : 288 - 293
  • [27] Atazanavir and atazanavir/ritonavir pharmacokinetics in HIV-infected infants, children, and adolescents
    Kiser, Jennifer J.
    Rutstein, Richard M.
    Samson, Pearl
    Graham, Bobbie
    Aldrovandi, Grace
    Mofenson, Lynne M.
    Smith, Elizabeth
    Schnittman, Steven
    Fenton, Terry
    Brundage, Richard C.
    Fletcher, Courtney V.
    AIDS, 2011, 25 (12) : 1489 - 1496
  • [28] Pharmacometric Characterization of Efavirenz Developmental Pharmacokinetics and Pharmacogenetics in HIV-Infected Children
    Salem, Ahmed Hamed
    Fletcher, Courtney V.
    Brundage, Richard C.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (01) : 136 - 143
  • [29] Pharmacokinetics of isoniazid, rifampicin, pyrazinamide and ethambutol in HIV-infected Indian children
    Mukherjee, A.
    Velpandian, T.
    Singla, M.
    Kanhiya, K.
    Kabra, S. K.
    Lodha, R.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2016, 20 (05) : 666 - 672
  • [30] Sertraline Pharmacokinetics in HIV-Infected and Uninfected Children, Adolescents, and Young Adults
    Hanan, Nathan John
    Paul, Mary Elizabeth
    Huo, Yanling
    Kapetanovic, Suad
    Smith, Elizabeth
    Siberry, George
    Brouwers, Pim
    Graham, Bobbie
    Johnston, Benjamin
    Capparelli, Edmund V.
    Best, Brookie M.
    FRONTIERS IN PEDIATRICS, 2019, 7
12345